After extensive research, Theracell has developed two very effective and safe products (namely Cytoprosthetic Hybrids) for the treatment of wounds, ulcers and burns. These Cytoprosthetic Hybrids are composed of cells (stem cells or fibroblasts, depending on the application) cultured on a special scaffold for the 3-D culture of the cells.
The following Cytoprosthetic Hybrids have been developed in our laboratories:
FibroDerm is a product that is composed of skin fibroblasts cultured on a thin membrane, a special scaffold, composed of an esterified form of hyaluronic acid.
StemDerm is a product that is composed of stem cells cultured on a thin membrane, a special scaffold, composed of an esterified form of hyaluronic acid.
Direct application of the Cytoprosthetic Hybrids on the wound, leads to:
- Full regeneration of the skin layers
- Migration of additional keratinocytes & fibroblasts
- Re-epithelization of the skin
Currently we curry out research to further improve the above Cytoprosthetic Hybrids and develop additional products in this category.